Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.1000
+0.0050 (5.26%)
May 21, 2026, 3:25 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 30.08 million as of May 21, 2026. Its market cap has increased by 135.82% in one year.
Market Cap
30.08M
Enterprise Value
134.71M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 30.08M, an increase of 31.14%. That is a compound annual growth rate of 1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 30.08M | 4.62% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 58.44M |
| Quantum BioPharma | 54.10M |
| Medicenna Therapeutics | 45.05M |
| MedMira | 42.10M |
| Lobe Sciences | 38.35M |
| Defence Therapeutics | 37.89M |
| Devonian Health Group | 31.01M |
| Microbix Biosystems | 31.00M |